N-3601

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameN-3601
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphoric diester hydrolases inhibitorsPotassium channel antagonistsVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelPotassium channelPhosphoric diester hydrolases
Therapy Area/IndicationsHeart FailureArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNisshin Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNisshin Pharma
Active IndicationsN/A
Inactive IndicationsHeart FailureArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A